| Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype J Toubiana, S Okada, J Hiller, M Oleastro, M Lagos Gomez, ... Blood, The Journal of the American Society of Hematology 127 (25), 3154-3164, 2016 | 490 | 2016 |
| COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience AM Shields, SO Burns, S Savic, AG Richter, A Anantharachagan, ... Journal of Allergy and Clinical Immunology 147 (3), 870-875. e1, 2021 | 225 | 2021 |
| Sequencing of human genomes with nanopore technology R Bowden, RW Davies, A Heger, AT Pagnamenta, M de Cesare, ... Nature communications 10 (1), 1869, 2019 | 200 | 2019 |
| Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme F Dhalla, SP Da Silva, M Lucas, S Travis, H Chapel Clinical & Experimental Immunology 165 (1), 1-7, 2011 | 136 | 2011 |
| Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation MT de la Morena, D Leonard, TR Torgerson, O Cabral-Marques, M Slatter, ... Journal of allergy and clinical immunology 139 (4), 1282-1292, 2017 | 128 | 2017 |
| Ageing compromises mouse thymus function and remodels epithelial cell differentiation J Baran-Gale, MD Morgan, S Maio, F Dhalla, I Calvo-Asensio, ... Elife 9, e56221, 2020 | 113 | 2020 |
| Antibody deficiency secondary to chronic lymphocytic leukemia: should patients be treated with prophylactic replacement immunoglobulin? F Dhalla, M Lucas, A Schuh, M Bhole, R Jain, SY Patel, S Misbah, ... Journal of clinical immunology 34, 277-282, 2014 | 110 | 2014 |
| Secondary immunodeficiency in lymphoproliferative malignancies V Friman, O Winqvist, C Blimark, P Langerbeins, H Chapel, F Dhalla Hematological oncology 34 (3), 121-132, 2016 | 87 | 2016 |
| Biologically indeterminate yet ordered promiscuous gene expression in single medullary thymic epithelial cells F Dhalla, J Baran‐Gale, S Maio, L Chappell, GA Holländer, CP Ponting The EMBO journal 39 (1), e101828, 2020 | 74 | 2020 |
| Challenges in the role of gammaglobulin replacement therapy and vaccination strategies for hematological malignancy S Sánchez-Ramón, F Dhalla, H Chapel Frontiers in immunology 7, 208268, 2016 | 63 | 2016 |
| Secondary antibody deficiencies F Dhalla, SA Misbah Current opinion in allergy and clinical immunology 15 (6), 505-513, 2015 | 58 | 2015 |
| Identification of a Novel Mutation in MAGT1 and Progressive Multifocal Leucoencephalopathy in a 58-Year-Old Man with XMEN Disease F Dhalla, S Murray, R Sadler, B Chaigne-Delalande, T Sadaoka, ... Journal of clinical immunology 35, 112-118, 2015 | 57 | 2015 |
| Investigation of UBE3A and MECP2 in Angelman syndrome (AS) and patients with features of AS MP Hitchins, S Rickard, F Dhalla, BBA de Vries, R Winter, ME Pembrey, ... American Journal of Medical Genetics Part A 125 (2), 167-172, 2004 | 47 | 2004 |
| FOXN1 deficient nude severe combined immunodeficiency IA Rota, F Dhalla Orphanet journal of rare diseases 12, 1-12, 2017 | 46 | 2017 |
| SARS-CoV-2 vaccine responses in individuals with antibody deficiency: findings from the COV-AD study AM Shields, SE Faustini, HJ Hill, S Al-Taei, C Tanner, F Ashford, ... Journal of clinical immunology 42 (5), 923-934, 2022 | 45 | 2022 |
| Chronic mucocutaneous candidiasis: characterization of a family with STAT-1 gain-of-function and development of an ex-vivo assay for Th17 deficiency of … F Dhalla, H Fox, EE Davenport, R Sadler, C Anzilotti, ... Clinical & Experimental Immunology 184 (2), 216-227, 2016 | 37 | 2016 |
| Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK AM Shields, A Anantharachagan, G Arumugakani, K Baker, S Bahal, ... Clinical and experimental immunology 209 (3), 247-258, 2022 | 33 | 2022 |
| Inborn errors of thymic stromal cell development and function AY Kreins, S Maio, F Dhalla Seminars in Immunopathology 43 (1), 85-100, 2021 | 21 | 2021 |
| Histology of interstitial lung disease in common variable immune deficiency F Dhalla, DJM Lochlainn, H Chapel, SY Patel Frontiers in Immunology 11, 605187, 2020 | 21 | 2020 |
| Increased seroprevalence and improved antibody responses following third primary SARS-CoV-2 immunisation: an update from the COV-AD study AM Shields, SE Faustini, HJ Hill, S Al-Taei, C Tanner, F Ashford, ... Frontiers in immunology 13, 912571, 2022 | 20 | 2022 |
